BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34092570)

  • 21. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
    Nobusawa S; Hirato J; Yokoo H
    Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome band 7q34 deletions resulting in KIAA1549-BRAF and FAM131B-BRAF fusions in pediatric low-grade Gliomas.
    Roth JJ; Santi M; Pollock AN; Harding BN; Rorke-Adams LB; Tooke LS; Biegel JA
    Brain Pathol; 2015 Mar; 25(2):182-92. PubMed ID: 25040262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation.
    Chai RC; Zhang YW; Liu YQ; Chang YZ; Pang B; Jiang T; Jia WQ; Wang YZ
    Acta Neuropathol Commun; 2020 Mar; 8(1):40. PubMed ID: 32228694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paediatric Gliomas: BRAF and Histone H3 as Biomarkers, Therapy and Perspective of Liquid Biopsies.
    Tan JY; Wijesinghe IVS; Alfarizal Kamarudin MN; Parhar I
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33557011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
    Ishi Y; Yamaguchi S; Hatanaka KC; Okamoto M; Motegi H; Kobayashi H; Terasaka S; Houkin K
    J Neurosurg; 2020 Feb; 134(3):733-741. PubMed ID: 32059187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated genomic analysis reveals actionable targets in pediatric spinal cord low-grade gliomas.
    Misove A; Vicha A; Broz P; Vanova K; Sumerauer D; Stolova L; Sramkova L; Koblizek M; Zamecnik J; Kyncl M; Holubova Z; Liby P; Taborsky J; Benes V; Pernikova I; Jones DTW; Sill M; Stancokova T; Krskova L; Zapotocky M
    Acta Neuropathol Commun; 2022 Sep; 10(1):143. PubMed ID: 36163281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system.
    Reis GF; Bloomer MM; Perry A; Phillips JJ; Grenert JP; Karnezis AN; Tihan T
    Mod Pathol; 2013 Oct; 26(10):1279-87. PubMed ID: 23702730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology.
    Hatae R; Hata N; Suzuki SO; Yoshimoto K; Kuga D; Murata H; Akagi Y; Sangatsuda Y; Iwaki T; Mizoguchi M; Iihara K
    Neuropathology; 2017 Jun; 37(3):191-199. PubMed ID: 27792249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients.
    Meredith DM; Cooley LD; Dubuc A; Morrissette J; Sussman RT; Nasrallah MP; Rathbun P; Yap KL; Wadhwani N; Bao L; Wolff DJ; Ida C; Sukhanova M; Horbinski C; Jennings LJ; Farooqi M; Gener M; Ginn K; Kam KL; Sasaki K; Kanagal-Shamanna R; Alexandrescu S; Brat D; Lu X
    Mod Pathol; 2023 Nov; 36(11):100294. PubMed ID: 37532182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric thalamic tumors in the MRI era: a Canadian perspective.
    Steinbok P; Gopalakrishnan CV; Hengel AR; Vitali AM; Poskitt K; Hawkins C; Drake J; Lamberti-Pasculli M; Ajani O; Hader W; Mehta V; McNeely PD; McDonald PJ; Ranger A; Vassilyadi M; Atkinson J; Ryall S; Eisenstat DD; Hukin J
    Childs Nerv Syst; 2016 Feb; 32(2):269-80. PubMed ID: 26597682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.
    Selt F; Hohloch J; Hielscher T; Sahm F; Capper D; Korshunov A; Usta D; Brabetz S; Ridinger J; Ecker J; Oehme I; Gronych J; Marquardt V; Pauck D; Bächli H; Stiles CD; von Deimling A; Remke M; Schuhmann MU; Pfister SM; Brummer T; Jones DT; Witt O; Milde T
    Oncotarget; 2017 Feb; 8(7):11460-11479. PubMed ID: 28002790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetics and therapeutic targets of pediatric low-grade gliomas.
    Tateishi K; Nakamura T; Yamamoto T
    Brain Tumor Pathol; 2019 Apr; 36(2):74-83. PubMed ID: 30929113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric low-grade gliomas.
    Sievert AJ; Fisher MJ
    J Child Neurol; 2009 Nov; 24(11):1397-408. PubMed ID: 19841428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metachronous, multicentric glioma of pilocytic astrocytoma with oligodendroglioma-like component and oligodendroglioma through distinct genetic aberrations.
    Kanoke A; Kanamori M; Kumabe T; Saito R; Watanabe M; Tominaga T
    J Neurosurg; 2013 Apr; 118(4):854-8. PubMed ID: 23082883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
    Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and clinicopathologic features of gliomas harboring NTRK fusions.
    Torre M; Vasudevaraja V; Serrano J; DeLorenzo M; Malinowski S; Blandin AF; Pages M; Ligon AH; Dong F; Meredith DM; Nasrallah MP; Horbinski C; Dahiya S; Ligon KL; Santi M; Ramkissoon SH; Filbin MG; Snuderl M; Alexandrescu S
    Acta Neuropathol Commun; 2020 Jul; 8(1):107. PubMed ID: 32665022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric low-grade gliomas and the need for new options for therapy: Why and how?
    Qaddoumi I; Sultan I; Broniscer A
    Cancer Biol Ther; 2009 Jan; 8(1):4-10. PubMed ID: 19164945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.
    Guerreiro Stucklin AS; Ryall S; Fukuoka K; Zapotocky M; Lassaletta A; Li C; Bridge T; Kim B; Arnoldo A; Kowalski PE; Zhong Y; Johnson M; Li C; Ramani AK; Siddaway R; Nobre LF; de Antonellis P; Dunham C; Cheng S; Boué DR; Finlay JL; Coven SL; de Prada I; Perez-Somarriba M; Faria CC; Grotzer MA; Rushing E; Sumerauer D; Zamecnik J; Krskova L; Garcia Ariza M; Cruz O; Morales La Madrid A; Solano P; Terashima K; Nakano Y; Ichimura K; Nagane M; Sakamoto H; Gil-da-Costa MJ; Silva R; Johnston DL; Michaud J; Wilson B; van Landeghem FKH; Oviedo A; McNeely PD; Crooks B; Fried I; Zhukova N; Hansford JR; Nageswararao A; Garzia L; Shago M; Brudno M; Irwin MS; Bartels U; Ramaswamy V; Bouffet E; Taylor MD; Tabori U; Hawkins C
    Nat Commun; 2019 Sep; 10(1):4343. PubMed ID: 31554817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.
    Richardson TE; Tang K; Vasudevaraja V; Serrano J; William CM; Mirchia K; Pierson CR; Leonard JR; AbdelBaki MS; Schieffer KM; Cottrell CE; Tovar-Spinoza Z; Comito MA; Boué DR; Jour G; Snuderl M
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1089-1099. PubMed ID: 31626289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilocytic astrocytomas: BRAFV600E and BRAF fusion expression patterns in pediatric and adult age groups.
    Kurani H; Gurav M; Shetty O; Chinnaswamy G; Moiyadi A; Gupta T; Jalali R; Epari S
    Childs Nerv Syst; 2019 Sep; 35(9):1525-1536. PubMed ID: 31321520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.